Moreover, enforced expression miR-211-5p contributes to BRAFi resistance by directly targeting DUSP6, which modulates the DUSP6-ERK5 signaling axis and promotes BRAFV600E driven melanoma growth and BRAFi/MEKi inhibitor resistance [40]. Here, DUSP6 is linked to melanoma.